Ironwood Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Ironwood Pharmaceuticals's balance sheet done over the years? Its assets were worth $471,073,000 last year, which is less than in the previous period. 174% of Ironwood Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $817,368,000, which means an increase by 82% compared compared to last year.
Debt to Assets
| 2014 | 333513000 | 244.96M | 73.45% |
|---|---|---|---|
| 2015 | 619121000 | 523.99M | 84.64% |
| 2016 | 709821000 | 643.10M | 90.6% |
| 2017 | 605674000 | 595.82M | 98.37% |
| 2018 | 332050000 | 528.42M | 159.14% |
| 2019 | 402748000 | 495.99M | 123.15% |
| 2020 | 559238000 | 496.59M | 88.8% |
| 2021 | 1126927000 | 521.01M | 46.23% |
| 2022 | 1100519000 | 448.14M | 40.72% |
| 2023 | 471073000 | 817.36M | 173.51% |
IRWD Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 92.15M | 656.20M | 620.12M | 362.56M | 177.02M | 173.17M | 125.73M | 54.00M | 261.28M | 74.29M |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 95.68M | 251.21M | 178.10M | 174.03M |
Net receivables | 129.12M | 115.45M | 114.04M | 122.35M | 117.24M | 80.95M | 82.15M | 64.85M | 54.51M | 25.83M |
Inventory | 0 | 1.25M | 1.25M | 1 | 648K | 0 | 735K | 1.08M | 0 | 4.95M |
Other current assets | 12.01M | 7.71M | 9.80M | 9.18M | 11.93M | 12.31M | 7.28M | 9.03M | 6.29M | 10.60M |
Total current assets | 233.28M | 780.62M | 745.22M | 495.83M | 306.85M | 266.43M | 311.59M | 380.18M | 500.20M | 289.73M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 18.17M | 20.31M | 22.92M | 25.50M | 30.17M | 17.27M | 17.27M | 20.51M | 21.07M | 29.82M |
Goodwill | 0 | 0 | 0 | 785K | 785K | 785K | 785K | 785K | 0 | 0 |
Intangible assets | 3.68M | 0 | 0 | 0 | 0 | 0 | 159.90M | 166.11M | 0 | 0 |
Long term investments | 0 | 15.07M | 24.48M | 36.95M | 64.93M | 0 | 115.24M | 0 | 95.21M | 0 |
Other non-current assets | 3.60M | 15.92M | 25.48M | 37.10M | 64.93M | 47.56M | 116.11M | 142.22M | 2.62M | 13.95M |
Total non-current assets | 237.78M | 319.89M | 381.70M | 63.39M | 95.89M | 65.61M | 294.07M | 329.64M | 118.91M | 43.78M |
Total assets | 471.07M | 1.10B | 1.12B | 559.23M | 402.74M | 332.05M | 605.67M | 709.82M | 619.12M | 333.51M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 39.46M | 28.38M | 875K | 252K | 195K | 7.71M | 7.19M | 7.19M |
Short term debt | 202.68M | 3.06M | 119.98M | 3.12M | 1.14M | 47.62M | 8.15M | 6.22M | 30.22M | 13.56M |
Total current liabilities | 276.10M | 25.52M | 161.69M | 32.71M | 40.92M | 119.52M | 66.02M | 91.13M | 76.46M | 60.54M |
| Non-current liabilities: | ||||||||||
Long term debt | 512.85M | 412.85M | 355.81M | 450.57M | 430.07M | 366.29M | 396.09M | 366.57M | 354.19M | 163.28M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 28.41M | 9.76M | 3.50M | 13.31M | 24.99M | 42.60M | 133.70M | 185.4M | 91.53M | 12.14M |
Total non-current liabilities | 541.26M | 422.61M | 359.31M | 463.88M | 455.07M | 408.89M | 529.79M | 551.97M | 447.53M | 184.42M |
Total liabilities | 817.36M | 448.14M | 521.01M | 496.59M | 495.99M | 528.42M | 595.82M | 643.10M | 523.99M | 244.96M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |